Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition
Bertolesix, Gabriel Esteban; Lauría de Cidre, Lilia; Sacerdote de Lustig, Eugenia; Eiján, Ana María; Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition; Elsevier; Cancer Letters; 90; 2; 14-4-1995; 123-131
Bertolesix, Gabriel Esteban
Lauría de Cidre, Lilia
Sacerdote de Lustig, Eugenia
Eiján, Ana María
Binding of heparin to primary cultured cells of two murine mammary adenocarcinomas with low (M3) and high (MM3) lung, metastatic capacity was determined. Heparin binding was rapid, specific and saturable. MM3 cells grown for 24 h in fetal calf serum (FCS)-free medium exhibited a higher number of binding sites for 3H-heparin [(11 ± 1) × 105 sites per cell] than M3 cells [(6.9 ± 0.6) × 105 sites per cell]. However, when M3 cells were grown in the presence of 2% FCS, they showed less heparin binding sites [(3.5 ± 0.4) × 105 sites per cell]. In contrast, dissociation constants were very similar for MM3 and M3 cells grown with or without FCS (Kd = 2−4 × 10−9M). Furthermore, heparin inhibited MM3 and M3 cell growth both in the absence or presence of FCS. Competition studies showed that chemically modified heparins lacking antiproliferative effect (O-desulfated; O/N-desulfated N-acetylated and N-desulfated heparins) were not able to inhibit 3H-heparin binding. N-desulfated N-acetylated heparin, which had partial antiproliferative effect, partially inhibited 3H-heparin binding, while heparin with a high antiproliferative activity inhibited more than 90% 3H-heparin binding. The antiproliferative effect of heparin and chemically modified heparins seems to be related to their binding ability to the cell membrane.